Filing Details
- Accession Number:
- 0001209191-18-025549
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-19 16:07:10
- Reporting Period:
- 2018-04-17
- Accepted Time:
- 2018-04-19 16:07:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367920 | Concert Pharmaceuticals Inc. | CNCE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1353528 | V James Cassella | C/O Concert Pharmaceuticals, Inc. 99 Hayden Avenue, Suite 500 Lexington MA 02421 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-04-17 | 10,582 | $20.18 | 30,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on February 8, 2018.
Billionaire Hedge Funds
